| Jan 18, 2023 | Synergia Medical | $4.1M Series B Extension | — | Jacques Berrebi, Invest.BW, InvestSud, Newton Biocapital, SFPI, TheClubDeal |
| Nov 3, 2022 | Novadip Biosciences | $23.6M Series B | — | Olivier van der Rest, Pierre Drion, CR-CP Life Science Fund, Fund+, InvestSud, VIVES Louvain Technology Fund |
| Feb 1, 2022 | Aerospacelab | $45.0M Series B | Airbus Ventures, XAnge | 360 Capital Partners, Didier Valet, Rand Hindi, BNP Paribas Private Equity, Sambrinvest, Nicolas Dhaene |
| Dec 6, 2021 | PDC*line Pharma | $26.2M Grant / Series B | Sangwoo Lee | Alpha Holdings, Brain Asset Management, Hansongneotech, Noshaq, Sambrinvest, Fontaine François, Smart Korea UTC Bio-Healthcare Venture Fund, Walloon Region |
| Oct 28, 2021 | Novadip Biosciences | $22.1M Series B | Jason Zhou | Fund+, Invest.BW, InvestSud, Franssen Christina, VIVES Louvain Technology Fund |
| Sep 30, 2021 | EsoBiotec | $7.0M Pre-Series A | — | Helena Pozios, Franssen Christina, Michel Briejer, Walloon Region |
| Sep 1, 2021 | Sortlist | $13.0M Series B | — | Diego DU MONCEAU, Rodolphe de Hemptinne, TheClubDeal |
| May 24, 2021 | ExeVir Bio | $50.0M Series A | Philippe Monteyne | Belgian family offices, Noshaq, Sambrinvest, Stef HEYLEN, MD, Caroline THIELEN, Erica Whittaker, Katja Rosenkranz, Jerome Van Biervliet, Joël Henneghien |
| Feb 17, 2021 | Imcyse | $25.8M Series B Extension | — | Biogenosis, Epimede, KU Leuven, LSP, Noshaq, Pfizer, SFPI-FPIM |
| Sep 2, 2020 | Miracor Medical SA | $28.5M Series E | — | Earlybird, Noshaq, Quest for Growth, SFPI-FPIM, Yonghua Capital |
| Mar 1, 2020 | ITeos Therapeutics | $130.0M Series B | Aaron Davis, Derek DiRocco | RA Capital, 6 Dimensions Capital, Curative Ventures, Fund+, HBM Partners, Invus, Janus Henderson Investors, MPM Capital, RTW Investments, SFPI, VIVES Louvain Technology Fund |
| Feb 14, 2020 | OncoDNA | $20.6M Series B | Robert Schier, Guy Geldhof | CPH Bank, Inventures, Sambrinvest, Fontaine François, Sofinim |
| Dec 17, 2019 | Odoo | $90.0M Other Equity | Antony Clavel | Noshaq, Sofinnova Ventures, Damien Lourtie, XAnge |
| Sep 1, 2019 | iSTAR Medical | $44.0M Series C | Bram Vanparys, PhD, MBA, Anne Portwich | EQT Life Sciences, BNP Paribas Fortis Private Equity, Capricorn Venture Partners, Lionel Carnot, SFPI-FPIM |
| Jun 18, 2019 | Imcyse | $38.8M Debt / Grant / Series B | LSP | Belfius, Biogenosis, DGO6, Marc Moles le Bailly, Paul Van Dun, Marc Foidart, Fontaine François, Franssen Christina |
| Sep 26, 2018 | Minoryx Therapeutics | $25.1M Series B | Philippe Monteyne | Caixa Capital Risc, Chiesi Ventures, HealthEquity, Idinvest Partners, Kurma Partners, Roche, Sambrinvest, SFPI, Gery Lefebvre, Ysios Capital |
| Jun 1, 2018 | ITeos Therapeutics | $75.0M Series B | MPM Capital | Atlas Venture, Hakan Goker, RA Capital, 6 Dimensions Capital, Curative Ventures, Fund+, Priyanka Belawat, SFPI, VIVES Louvain Technology Fund |
| Feb 19, 2018 | Synergia Medical | $10.1M Series A | Alain Parthoens | Pierre Detrixhe, SFPI-FPIM |
| Feb 9, 2018 | Syndesi Therapeutics | $20.8M Series A | Fountain Healthcare Partners, Novo Seeds | Johnson & Johnson Innovation, V-Bio Ventures, VIVES Louvain Technology Fund |
| Jan 12, 2018 | Qualifio | $3.6M Series A | — | Damien Lourtie, Frank Maene |
| Nov 17, 2017 | Ncardia | $12.4M Series B | Marc Foidart | InnovationQuarter, Sambrinvest, SFPI-FPIM, Vesalius Biocapital |
| Aug 1, 2017 | Elium | $5.0M Series A | Marc Fournier | Chalfen Ventures, Serena Capital |
| Oct 28, 2016 | Promethera Biosciences | $10.9M Series C Extension | — | Boehringer Ingelheim, Cell Innovation Partners, Fund+, LifeLiver, Muneki Handa, SMS Investments, Vesalius Biocapital |
| Sep 4, 2016 | OncoDNA | $8.6M Other Equity | — | Crown Predator Holdings, Inventures, Invest4OncoDNA, IPG/bio.be, Sambrinvest, Sofinim, Vinsovier |
| Apr 12, 2016 | iSTAR Medical | $11.4M Series B | — | Capricorn Venture Partners, Fond Europ des Mat riaux, SFPI-FPIM, Startup Capital Ventures |
